Market Research Report
Intravenous (IV) Therapy and Vein Access: Global Markets
|Published by||BCC Research||Product code||128360|
|Published||Content info||259 Pages
Delivery time: 1-2 business days
|Intravenous (IV) Therapy and Vein Access: Global Markets|
|Published: December 19, 2018||Content info: 259 Pages||
The global market for IV therapy and vein access will grow from nearly $40.7 billion in 2018 to $54.5 billion by 2023 with a compound annual growth rate (CAGR) of 6.0% for the period of 2018-2023.
IV solutions and sets market will grow from $17.9 billion in 2018 to nearly $24.1 billion by 2023 with a CAGR of 6.1%.
Infusion pumps market will grow from nearly $15.9 billion in 2018 to nearly $21.2 billion by 2023 with a CAGR of 5.9%.
This report focuses on the global market for IV therapy and vein access devices and provides an updated review that includes applications in various care facility settings.
The scope of this study encompasses different types of IV solutions and devices used for therapeutic purposes. BCC Research studied and analyzed the market for key components including different types of intravenous solutions and sets (general IV solutions and sets, parenteral nutrition IV solutions and sets and premixed drug IV solutions and sets), infusion pumps (large-volume infusion pumps, syringe infusion pumps, ambulatory/disposable infusion pumps, insulin infusion pumps, PCA infusion pumps, enteraI feeding pumps and implantable infusion pumps) and vein access devices (peripheral intravenous catheters and central venous catheters).
Below are the details of product inclusions studied for each market segment under IV solutions and sets:
This report covers associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy. In addition, the study also covers the market projections, market leaders and market shares for the global IV therapy and vein access market.
The geographical regions covered in the report are North America, Europe and rest of the world markets. The rest of the world segment includes the markets for countries such as India, China, Japan, South Korea, Taiwan, parts of Africa, Australia, New Zealand, etc.
This report also contains a relevant patent analysis and comprehensive company profiles for leaders in the IV therapy and vein access devices industry. The market is dominated by a few major players including B. Braun Melsungen; Baxter International; Becton Dickinson and Co. (CareFusion Corp., C. R. Bard,); Fresenius Kabi; ICU Medical (Hospira); Medtronic.; Smiths Group. (Smiths Medical) Teleflex, Insulet Corp., Tandem Diabetes Care and Nestle Health Science.